BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1620351)

  • 1. Botulinum toxin treatment of supranuclear ocular motility disorders.
    Newman NJ; Lambert SR
    Neurology; 1992 Jul; 42(7):1391-3. PubMed ID: 1620351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin in the management of internuclear ophthalmoplegia.
    Murthy R; Dawson E; Khan S; Adams GG; Lee J
    J AAPOS; 2007 Oct; 11(5):456-9. PubMed ID: 17498988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin in the management of acquired motor fusion deficiency.
    Murthy R; Kesarwani S
    Indian J Ophthalmol; 2009; 57(6):463-4. PubMed ID: 19861751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of strabismus with botulinum toxin].
    Cordonnier M; van Nechel C; van den Ende P; Zumaran C; Benammar L
    J Fr Ophtalmol; 1994; 17(12):755-68. PubMed ID: 7722237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unsatisfactory treatment of acquired nystagmus with retrobulbar injection of botulinum toxin.
    Tomsak RL; Remler BF; Averbuch-Heller L; Chandran M; Leigh RJ
    Am J Ophthalmol; 1995 Apr; 119(4):489-96. PubMed ID: 7709974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of supranuclear and internuclear ocular motility disorders.
    Buckley SA; Elston JS
    Eye (Lond); 1997; 11 ( Pt 3)():377-80. PubMed ID: 9373480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of botulinum toxin in strabismus].
    Wabbels B
    Ophthalmologe; 2016 Jul; 113(7):544-9. PubMed ID: 27369733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binocular diplopia in unilateral aphakia: the role of botulinum toxin.
    Hakin KN; Lee JP
    Eye (Lond); 1991; 5 ( Pt 4)():447-50. PubMed ID: 1743360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical application of botulinum toxin].
    Grandas F
    Neurologia; 1995; 10(6):224-33. PubMed ID: 7546812
    [No Abstract]   [Full Text] [Related]  

  • 10. Eye movement disorders.
    Liu GT; Volpe NJ; Galetta SL
    Curr Opin Ophthalmol; 1995 Dec; 6(6):27-33. PubMed ID: 10160415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evidence of extraocular muscle fiber-type specificity of botulinum toxin.
    Stahl JS; Averbuch-Heller L; Remler BF; Leigh RJ
    Neurology; 1998 Oct; 51(4):1093-9. PubMed ID: 9781535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin treatment versus conservative management in acute traumatic sixth nerve palsy or paresis.
    Holmes JM; Beck RW; Kip KE; Droste PJ; Leske DA
    J AAPOS; 2000 Jun; 4(3):145-9. PubMed ID: 10849389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internuclear and supranuclear disorders of eye movements: clinical features and causes.
    Karatas M
    Eur J Neurol; 2009 Dec; 16(12):1265-77. PubMed ID: 19723293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin treatment of "one and a half syndrome".
    Kipioti A; Taylor RH
    Br J Ophthalmol; 2003 Jul; 87(7):918-9. PubMed ID: 12812899
    [No Abstract]   [Full Text] [Related]  

  • 15. Injection of type A botulinum toxin into extraocular muscles for correction of strabismus.
    Flanders M; Tischler A; Wise J; Williams F; Beneish R; Auger N
    Can J Ophthalmol; 1987 Jun; 22(4):212-7. PubMed ID: 3607594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wall-eyed bilateral internuclear ophthalmoplegia: review of pathogenesis, diagnosis, prognosis and management.
    Wu YT; Cafiero-Chin M; Marques C
    Clin Exp Optom; 2015 Jan; 98(1):25-30. PubMed ID: 25308307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
    Kupersmith MJ; Ying G
    Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin in the management of acquired motor fusion deficiency: the missing links.
    Pandey PK; Dadeya S; Vats P; Singh A; Rathi N; Dangda S
    Indian J Ophthalmol; 2010; 58(5):446; author reply 446-7. PubMed ID: 20689210
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic eye movement induced pain and a possible role for its treatment with botulinum toxin.
    Burton BJ; Khan SR; Lee JP
    Br J Ophthalmol; 2003 Sep; 87(9):1194-5. PubMed ID: 12928305
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of ocular motility disturbances in Graves' disease with botulinum toxin A.
    Stiglmayer N; Lesin M; Juri J; Ivanisević M; Boić L; Rogosić V
    Coll Antropol; 2005; 29 Suppl 1():41-6. PubMed ID: 16193675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.